Indications for use
Symptomatic treatment of chronic obstructive diseases of airways with reversible airway obstruction, such as bronchial asthma, chronic obstructive pulmonary disease (COPD), chronic obstructive bronchitis with or without emphysema
IPRATEROL
International name
ipratropium bromide + fenoterol
Medicines
Pulmonology
Dosed form
Solutions for inhalation
Dosage
20+50 mcg/dose
ATX Code :
R03AL01